Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 4Phase NA 2Phase 1/2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2CNS 2

Conditions

Glioblastoma 7Glioma 5Central Nervous System Neoplasms 5Brain Neoplasms 3Astrocytoma 3Oligodendroglioma 2Lymphoma 2Gliosarcoma 2Spinal Cord Neoplasms 1Sarcoma 1Recurrence 1Neoplasms 1Leiomyosarcoma 1Hyperthermia 1Ependymoma 1Depression 1

Interventions

Cyclophosphamide 25Rituximab 18fludarabine phosphate 15Radiotherapy 13Methotrexate 13Peripheral Blood Stem Cell Transplantation 12Filgrastim 12Cytarabine 12Vincristine 11Melphalan 10Cyclosporine 10Busulfan 10Antilymphocyte Serum 10Exercise 9Doxorubicin 9Prednisone 7Mycophenolic Acid 7Magnetic Resonance Spectroscopy 7Etoposide 7Early Intervention, Educational 7Whole-Body Irradiation 6Surveys and Questionnaires 6Prednisolone 6Palliative Care 6Methods 6Leucovorin 6Educational Status 6Blood Specimen Collection 6Dexamethasone 5pegylated granulocyte colony-stimulating factor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Lymphoma × Temozolomide × Clear all
NCT00109798 2017-09-19

Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma

The Methodist Hospital Research Institute

Phase NA Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

NCT00416819 2015-08-20

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

University of California, San Francisco

Phase NA Completed
10 enrolled
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡